1. Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices;de la Torre;Clin. Pharmacokinet.,2004
2. Substance Abuse and Mental Health Services Administration (SAMHSA). Mandatory guidelines for federal workplace drug testing programs - oral/fluid. Access in may: https://www.samhsa.gov/sites/default/files/programs_campaigns/division_workplace_programs/final-mg-oral-fluid.pdf.
3. European Workplace Drug Testing Society (EWDTS), European Guidelines for Workplace in Oral Fluid, 2015, Version 2.0. access in may: http://www.ewdts.org/data/uploads/documents/ewdts-oral-fluid-2015-11-01-v2.0.pdf.
4. United Nations International Drug Control Programme (UNDCP). Rapid on-site screening of drugs of abuse - A summary of commercially available products and their applications: guidance for the selection of suitable products Part I Biological specimens. access in may: https://www.unodc.org/pdf/scientific/Scitec18_final1.pdf.
5. Oral fluid and plasma 3,4-ethylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration;Desrosiers;Anal. Bioanal. Chem.,2013